期刊文献+

Trends in the major causes of death in China, 1982-2010 被引量:14

Trends in the major causes of death in China, 1982-2010
原文传递
导出
摘要 Since the introduction of a series of reform and open policies in its economic system in 1976,China has been in a boom period of social and economic fields.Rapid development in economy and the consequent improvement in living conditions,nutrition,and health care help to decrease infant mortality and deaths from infectious diseases,and notably effected the patterns of mortality.For example,respiratory diseases,acute infectious diseases,and tuberculosis were the leading causes of death in 1957,while diseases of heart,cerebrovascular disease,and malignant neoplasm were the fifth,sixth,and seventh leading causes of death.1 Up to 1975,cerebrovascular diseases,diseases of heart,and malignant neoplasm were the top three death causes,followed by respiratory diseases,digestive diseases,and pulmonary tuberculosis.1 A prospective cohort study involving a representative sample of the adult Chinese population was conducted in 2005,which revealed that the five leading causes of death were malignant neoplasm,diseases of heart,cerebrovascular disease,accidents,and infectious diseases among men and diseases of heart,cerebrovascular disease,malignant neoplasm,pneumonia and influenza,and infectious diseases among women. Since the introduction of a series of reform and open policies in its economic system in 1976,China has been in a boom period of social and economic fields.Rapid development in economy and the consequent improvement in living conditions,nutrition,and health care help to decrease infant mortality and deaths from infectious diseases,and notably effected the patterns of mortality.For example,respiratory diseases,acute infectious diseases,and tuberculosis were the leading causes of death in 1957,while diseases of heart,cerebrovascular disease,and malignant neoplasm were the fifth,sixth,and seventh leading causes of death.1 Up to 1975,cerebrovascular diseases,diseases of heart,and malignant neoplasm were the top three death causes,followed by respiratory diseases,digestive diseases,and pulmonary tuberculosis.1 A prospective cohort study involving a representative sample of the adult Chinese population was conducted in 2005,which revealed that the five leading causes of death were malignant neoplasm,diseases of heart,cerebrovascular disease,accidents,and infectious diseases among men and diseases of heart,cerebrovascular disease,malignant neoplasm,pneumonia and influenza,and infectious diseases among women.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第4期777-781,共5页 中华医学杂志(英文版)
关键词 causes of death MORTALITY CANCER causes of death mortality cancer
  • 相关文献

同被引文献94

  • 1朱寿田,楼善贤,施红旗,徐庆才,王利霞,刘庆伟,毛醒洁.猝死37例死因分析[J].临床与实验病理学杂志,2004,20(3):303-305. 被引量:16
  • 2秦威,许寒冰,庄建国.1981—2005年昆山市恶性肿瘤死亡情况分析[J].中国慢性病预防与控制,2007,15(5):495-496. 被引量:2
  • 3LIU 1. Cardiovascular diseases in China[J]. Biochem Cell Bioi, 2007,85(2) :157-163.
  • 4MORAN A, GU D, ZHAO D, et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china[J]. Circ Cardiovasc Qual Outcomes, 2010,3 (3) :243-252.
  • 5STONE NJ, ROBINSONJ G, LICHTENSTEIN A H, et al. 2013 ACC/ AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am Coli Cardiol, 2014,63 (25 Pt B) : 2889 -2934.
  • 6AVIS HJ, HUTTEN B A, GAGNE C, et al. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia[J].JAm Coli Cardiol, 2010,55(11) :1121-1126.
  • 7MORIARTY PM,JACOBSON T A, BRUCKERT E, et al. Effi- cacy and safety of alirocumab, a monoclonal antibody to PCSK9 , in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial[J].J Clin Lipidol , 2014,8 (6) :554-56l.
  • 8REINER Z, CATAPANO A L, DE BACKER G, et al. ESC/EAS Guidelines for the management of dyslipidaemias , the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)[J]. Eur HeartJ, 2011 ,32(14) :1769-1818.
  • 9ABIFADEL M, V ARRET M, RABESJ P, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia[J]. Nat Genet, 2003,34(2) :154-156.
  • 10DlAS C S, SHA YWITZ AJ , WASSERMAN S M, et al. Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascendingdose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins[J].J Am Call Cardiol, 2012, 60 (19) : 1888-1898.

引证文献14

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部